{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:46:50Z","timestamp":1785757610353,"version":"3.56.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32DK007695"],"award-info":[{"award-number":["T32DK007695"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005627","name":"Thrasher Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5R35GM146701"],"award-info":[{"award-number":["5R35GM146701"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijantimicag.2026.107741","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:44:35Z","timestamp":1770914675000},"page":"107741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urine NGAL adds to serum creatinine in predicting cefepime clearance in critically ill children at high risk of acute kidney injury"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1218-8293","authenticated-orcid":false,"given":"Horace Rhodes","family":"Hambrick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5856-3717","authenticated-orcid":false,"given":"Ronaldo Morales","family":"Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calise","family":"Curry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8471-9826","authenticated-orcid":false,"given":"Tomoyuki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3275-2982","authenticated-orcid":false,"given":"Kelli A.","family":"Krallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart L.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7737-8499","authenticated-orcid":false,"given":"Sonya","family":"Tang Girdwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2026.107741_bib0001","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1586\/14787210.6.6.805","article-title":"Cefepime: a reapprasial in an era of increasing antimicrobial resistance","volume":"6","author":"Endimiani","year":"2008","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0002","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/jac\/dkad106","article-title":"Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients","volume":"78","author":"An","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0003","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nrmicro862","article-title":"Antimicrobial pharmacodynamics: critical interactions of \u201cbug and drug","volume":"2","author":"Drusano","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0004","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3390\/antibiotics12040681","article-title":"The current status and future perspectives of beta-lactam therapeutic drug monitoring in critically ill patients","volume":"12","author":"Novy","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1186\/s13054-014-0671-1","article-title":"The early antibiotic therapy in septic patients\u2013milestone or sticking point?","volume":"18","author":"Bernhard","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0006","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/jac\/dkz476","article-title":"A retrospective study to determine the cefepime-induced neurotoxicity threshold in hospitalized patients","volume":"75","author":"Lau","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-017-1856-1","article-title":"Cefepime-induced neurotoxicity: a systematic review","volume":"21","author":"Payne","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.chest.2020.01.051","article-title":"Effect of cefepime on neurotoxicity development in critically ill adults with renal dysfunction","volume":"158","author":"Khan","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0009","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/ccr3.1217","article-title":"Cefepime-induced neurotoxicity in a pediatric patient on chronic hemodialysis: a case report","volume":"5","author":"Guzman-Limon","year":"2017","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0010","first-page":"199","article-title":"Cefepime-induced neurotoxicity despite dose adjustment for renal disease: a brief report and review of the literature","volume":"6","author":"Lindsay","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"6","key":"10.1016\/j.ijantimicag.2026.107741_bib0011","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.pediatrneurol.2012.08.017","article-title":"Pediatric cefepime neurotoxicity","volume":"47","author":"Landgrave","year":"2012","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0012","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/08971900221125000","article-title":"Cefepime-associated neurotoxicity in a pediatric patient with stage V chronic kidney disease","volume":"37","author":"Hambrick","year":"2024","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0013","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00467-024-06477-4","article-title":"Acute kidney injury is associated with abnormal cefepime exposure among critically ill children and young adults","volume":"40","author":"Pavia","year":"2025","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0014","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ki.1985.101","article-title":"Course of acute renal failure studied by a model of creatinine kinetics","volume":"27","author":"Moran","year":"1985","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41581-018-0080-9","article-title":"Estimated GFR: time for a critical appraisal","volume":"15","author":"Porrini","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0016","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00134-023-07198-2","article-title":"Subclinical and clinical acute kidney injury share similar urinary peptide signatures and prognosis","volume":"49","author":"Boutin","year":"2023","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0017","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2215\/CJN.14181021","article-title":"Overview of diagnostic criteria and epidemiology of acute kidney injury and acute kidney disease in the critically ill patient","volume":"17","author":"Birkelo","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0018","first-page":"137","article-title":"Biomarkers of acute kidney injury: time to learn from implementations","volume":"23","author":"Endre","year":"2021","journal-title":"Crit Care Resusc"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0019","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000364937","article-title":"The rise and fall of NGAL in acute kidney injury","volume":"37","author":"M\u00e5rtensson","year":"2014","journal-title":"Blood Purif"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0020","first-page":"47","article-title":"Urinary neutrophil gelatinase-associated lipocalin (NGAL) as an early marker of acute kidney injury in critically ill multiple trauma patients","author":"Makris","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0021","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ekir.2016.07.003","article-title":"Urinary NGAL-positive acute kidney injury and poor long-term outcomes in hospitalized patients","volume":"1","author":"Singer","year":"2016","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0022","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1053\/j.ajkd.2020.05.015","article-title":"Neutrophil gelatinase-associated lipocalin measured on clinical laboratory platforms for the prediction of acute kidney injury and the associated need for dialysis therapy: a systematic review and meta-analysis","volume":"76","author":"Albert","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0023","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.ekir.2022.05.021","article-title":"Integration of the Renal Angina index and urine neutrophil gelatinase-associated lipocalin improves severe acute kidney injury prediction in critically ill children and young adults","volume":"7","author":"Goldstein","year":"2022","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0024","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/jac\/dkw351","article-title":"Urinary kidney injury biomarkers and tobramycin clearance among children and young adults with cystic fibrosis: a population pharmacokinetic analysis","volume":"72","author":"Downes","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0025","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000004784","article-title":"Urinary biomarkers and attainment of cefepime therapeutic targets in critically ill children","author":"Downes","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0026","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/FTD.0000000000000496","article-title":"Acute kidney injury biomarkers predict an increase in serum milrinone concentration earlier than serum creatinine-defined Acute kidney injury in infants after cardiac surgery","volume":"40","author":"Gist","year":"2018","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0027","first-page":"1","article-title":"Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury","volume":"2","author":"Kellum","year":"2012","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0028","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.ekir.2023.09.019","article-title":"Real-time acute kidney injury risk stratification\u2013Biomarker directed fluid management improves outcomes in critically ill children and young adults","volume":"8","author":"Goldstein","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0029","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jcph.1773","article-title":"Demonstrating feasibility of an opportunistic sampling approach for pharmacokinetic studies of \u03b2-lactam antibiotics in critically ill children","volume":"61","author":"Tang Girdwood","year":"2021","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0030","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0031","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New creatinine- and cystatin C\u2013Based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0032","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0033","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s00467-019-04294-8","article-title":"Use of height-independent baseline creatinine imputation method with renal angina index","volume":"34","author":"Roy","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0034","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s40262-025-01485-5","article-title":"Population pharmacokinetics of cefepime in critically ill children and young adults: model development and external validation for Monte Carlo simulations and model-informed precision dosing","volume":"64","author":"Morales Junior","year":"2025","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0035","first-page":"66","article-title":"Population pharmacokinetic modeling of total and free ceftriaxone in critically ill children and young adults and Monte Carlo simulations support twice daily dosing for target attainment","author":"Tang Girdwood","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0036","unstructured":"CLSI. Performance standards for antimicrobial susceptibility testing. 2025. https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m100\/ [accessed 24.06.25]"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0037","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s40262-022-01137-y","article-title":"Clinical pharmacokinetics and pharmacodynamics of cefepime","volume":"61","author":"Pais","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.889958","article-title":"Antimicrobial dosing recommendations in pediatric continuous renal replacement therapy: a critical appraisal of current evidence","author":"Stitt","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ijantimicag.2026.107741_bib0039","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40560-024-00752-0","article-title":"Monte Carlo simulations of cefepime in children receiving continuous kidney replacement therapy support continuous infusions for target attainment","volume":"12","author":"Hambrick","year":"2024","journal-title":"J Intensive Care"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857926000300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:04:09Z","timestamp":1785755049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857926000300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0924857926000300"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107741","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urine NGAL adds to serum creatinine in predicting cefepime clearance in critically ill children at high risk of acute kidney injury","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2026.107741","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107741"}}